Pharmacokinetics of cefoperazone in patients with neoplastic disease.
The pharmacokinetics of cefoperazone, a new semisynthetic cephalosporin, were studied in 34 patients with neoplastic disease. This compound was administered in a variety of doses and schedules without observable toxicity in any patient. The mean peak serum concentration after a 15-min intravenous in...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1981
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC181604/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6455966/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.19.6.1037 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
